Research Question
Ectopic fat deposition is emerging as a critical factor in multiorgan dysfunction, with significant global health implications. Obesity-related diseases, such as cardiovascular disease, liver dysfunction, and insulin resistance, are major contributors to the global disease burden. Despite increasing prevalence, effective prevention or reversal strategies remain limited. This study aims to uncover the underlying mechanisms driving multiorgan dysfunction to inform targeted therapeutic interventions.
Objective
The study investigates how ectopic fat deposition contributes to multiorgan dysfunction using a multi-omics approach. It will explore the molecular mechanisms linking ectopic fat accumulation in tissues like the liver, muscle, and heart to metabolic disturbances and organ-specific dysfunctions. By integrating genomic, transcriptomic, and metabolomic data, the research seeks to identify biomarkers and pathways driving obesity-related organ dysfunctions.
Scientific Rationale
Ectopic fat deposition is increasingly recognized as a key driver of multiorgan dysfunction, but its precise molecular mechanisms are poorly understood. While existing studies highlight associations between ectopic fat and diseases such as metabolic syndrome and cardiovascular issues, they often lack comprehensive insights into the underlying biology and causal relationships. Traditional studies focus on isolated biomarkers or single-organ dysfunction. This research addresses these gaps by integrating multi-omics approaches (proteomics, metabolomics, and genomics) to provide a holistic understanding of how ectopic fat influences multiple organs. By combining these methods with large-scale epidemiological data, we aim to identify novel biomarkers, unravel causal pathways, and offer more definitive evidence for the role of ectopic fat in disease progression. This integrative approach promises to advance our understanding.